首页 > 最新文献

Journal of intensive medicine最新文献

英文 中文
The reliability of the plethysmographic perfusion index for detecting fluid responsiveness in critically ill patients 容积脉搏血流灌注指数检测危重病人液体反应性的可靠性。
Pub Date : 2026-02-01 Epub Date: 2025-09-27 DOI: 10.1016/j.jointm.2025.07.004
Younes Aissaoui, Ayoub Bouchama, Chaimae Abouelkemhe, Abdellah Enourhbi, Bassam Bencharfa, Mehdi Didi, Hatim Aguena, Ayoub Belhadj

Background

The assessment of fluid responsiveness (FR) is critical during the initial management of acute circulatory failure (ACF). However, in resource-limited settings or emergency situations, advanced hemodynamic monitoring is often unavailable. The plethysmographic perfusion index (PPI), a non-invasive parameter derived from pulse oximetry, has been proposed as a surrogate marker for changes in cardiac output. The objective of this study was to evaluate the ability of the PPI to detect FR in critically ill patients with ACF during early resuscitation.

Methods

This was a prospective observational study conducted over seven months (February to September 2024) in a 10-bed intensive care unit. Adult patients with ACF requiring a 500-mL fluid bolus were enrolled. FR was assessed by transthoracic echocardiography, defined as a ≥ 15% increase in left ventricular outflow tract velocity-time integral (VTI). VTI and PPI values were obtained before and immediately after the completion of fluid administration. The diagnostic performance of changes in PPI (ΔPPI) was assessed using receiver operating characteristic (ROC) curve analysis and a gray zone approach.

Results

Fifty patients (29 males and 21 females) were included, with a median age of 65 years (interquartile range [IQR]: 57–77). Sepsis-related ACF accounted for 60% of cases. FR was observed in 33 patients (66%). The area under the ROC curve (AUC) for ΔPPI was 0.778 (95% CI: 0.638 to 0.883, P = 0.004). A ΔPPI threshold of 33% yielded 70% sensitivity and 82% specificity. The gray zone ranged from 0% to 88%, encompassing 30% of the cohort.

Conclusion

The PPI demonstrated moderate accuracy in detecting FR during early resuscitation of ACF. As a simple, non-invasive, and widely accessible tool, PPI holds promise for informing fluid management decisions in emergency and critical care settings. Further technological refinements may enhance its diagnostic performance and broaden its clinical applicability.
Trial registration Clinical Trials.gov Identifier: NCT06313671.
背景:在急性循环衰竭(ACF)的初始治疗中,液体反应性(FR)的评估是至关重要的。然而,在资源有限的情况下或紧急情况下,往往无法进行先进的血流动力学监测。容积血流灌注指数(PPI)是一种由脉搏血氧测定法衍生的无创参数,已被提议作为心输出量变化的替代指标。本研究的目的是评估急性心衰危重患者早期复苏时PPI检测FR的能力。方法:这是一项前瞻性观察研究,为期7个月(2024年2月至9月),在10张床位的重症监护病房进行。纳入需要500毫升液体丸的ACF成年患者。FR通过经胸超声心动图评估,定义为左心室流出道速度-时间积分(VTI)增加≥15%。在给药前和结束后立即测量VTI和PPI值。采用受试者工作特征(ROC)曲线分析和灰色地带法评估PPI变化的诊断性能(ΔPPI)。结果:纳入50例患者,其中男性29例,女性21例,中位年龄65岁(四分位数间距[IQR]: 57-77)。败血症相关ACF占60%。33例(66%)患者发生FR。ΔPPI的ROC曲线下面积为0.778 (95% CI: 0.638 ~ 0.883, P = 0.004)。33%的ΔPPI阈值产生70%的敏感性和82%的特异性。灰色地带的范围从0%到88%不等,包括30%的队列。结论:在ACF早期复苏过程中,PPI检测FR的准确性中等。作为一种简单、无创、可广泛使用的工具,PPI有望为急诊和重症监护环境中的流体管理决策提供信息。进一步的技术改进可能会提高其诊断性能并扩大其临床适用性。临床试验。gov标识符:NCT06313671。
{"title":"The reliability of the plethysmographic perfusion index for detecting fluid responsiveness in critically ill patients","authors":"Younes Aissaoui,&nbsp;Ayoub Bouchama,&nbsp;Chaimae Abouelkemhe,&nbsp;Abdellah Enourhbi,&nbsp;Bassam Bencharfa,&nbsp;Mehdi Didi,&nbsp;Hatim Aguena,&nbsp;Ayoub Belhadj","doi":"10.1016/j.jointm.2025.07.004","DOIUrl":"10.1016/j.jointm.2025.07.004","url":null,"abstract":"<div><h3>Background</h3><div>The assessment of fluid responsiveness (FR) is critical during the initial management of acute circulatory failure (ACF). However, in resource-limited settings or emergency situations, advanced hemodynamic monitoring is often unavailable. The plethysmographic perfusion index (PPI), a non-invasive parameter derived from pulse oximetry, has been proposed as a surrogate marker for changes in cardiac output. The objective of this study was to evaluate the ability of the PPI to detect FR in critically ill patients with ACF during early resuscitation.</div></div><div><h3>Methods</h3><div>This was a prospective observational study conducted over seven months (February to September 2024) in a 10-bed intensive care unit. Adult patients with ACF requiring a 500-mL fluid bolus were enrolled. FR was assessed by transthoracic echocardiography, defined as <em>a</em> ≥ 15% increase in left ventricular outflow tract velocity-time integral (VTI). VTI and PPI values were obtained before and immediately after the completion of fluid administration. The diagnostic performance of changes in PPI (ΔPPI) was assessed using receiver operating characteristic (ROC) curve analysis and a gray zone approach.</div></div><div><h3>Results</h3><div>Fifty patients (29 males and 21 females) were included, with a median age of 65 years (interquartile range [IQR]: 57–77). Sepsis-related ACF accounted for 60% of cases. FR was observed in 33 patients (66%). The area under the ROC curve (AUC) for ΔPPI was 0.778 (95% CI: 0.638 to 0.883, <em>P</em> = 0.004). A ΔPPI threshold of 33% yielded 70% sensitivity and 82% specificity. The gray zone ranged from 0% to 88%, encompassing 30% of the cohort.</div></div><div><h3>Conclusion</h3><div>The PPI demonstrated moderate accuracy in detecting FR during early resuscitation of ACF. As a simple, non-invasive, and widely accessible tool, PPI holds promise for informing fluid management decisions in emergency and critical care settings. Further technological refinements may enhance its diagnostic performance and broaden its clinical applicability.</div><div><strong>Trial registration</strong> Clinical Trials.gov Identifier: NCT06313671.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 34-41"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vasoactive drugs and the distribution of crystalloid fluid during acute sepsis 急性脓毒症时血管活性药物与结晶液的分布。
Pub Date : 2026-02-01 Epub Date: 2025-10-17 DOI: 10.1016/j.jointm.2025.08.008
Robert G. Hahn , Yuhong Li , Randal O. Dull

Background

Crystalloid fluid is combined with vasoactive drugs when treating acute sepsis. We used kinetic analysis to compare the effects of vasoactive drugs on the hemodynamics and the volume kinetics of crystalloid fluid in non-septic and septic sheep. Specific attention was given to the effects of drugs and sepsis on fluid distribution to the “third fluid space.”

Methods

Forty-nine sheep were studied, of which 25 were made septic by cecal puncture and administration of lipopolysaccharide. A bolus infusion of 20–25 mL/kg of crystalloid fluid was given 1 h later, together with therapeutic doses of phenylephrine, norepinephrine, isoprenaline, dopamine, or esmolol. Central hemodynamics were monitored, and blood samples for the calculation of volume kinetics were taken. The distribution and elimination of the infused volume were calculated using mixed-model kinetics with extensive covariate analyses based on 1134 measurements of the hemoglobin-derived plasma dilution (23 per experiment) and 193 measurements of urine output collected over 180 min.

Results

Sepsis induced a hyperkinetic, hypotensive, and vasodilatory state. Cardiac output averaged 12.1 L/min in septic sheep vs. 7.6 L/min in non-septic sheep, and mean arterial pressure was 72 vs. 109 mmHg, respectively. Differences in hemodynamic variables between the non-septic and septic sheep were all statistically significant (P <0.001). However, the modifying influences of vasopressors on hemodynamics and fluid distribution were weakened in the septic state. The rate constant for urine output (k10) was strongly decreased by sepsis, modestly reduced by β1-adrenergic stimulation, and increased by α1-adrenergic stimulation. Fluid was able to access the remote slow-exchange interstitial fluid space (“third fluid space”) only during sepsis. In theory, fluid accumulation in this space would decrease by α1-adrenergic stimulation and increase by β1-adrenergic stimulation, but differences were small due to the overall weak effects of adrenergic drugs in the septic sheep. We hypothesize that the changeover from brisk urine flow in the non-septic sheep to marked accumulation of fluid in the “third fluid space” was due to inflammation-induced alterations in the interstitial matrix.

Conclusion

Vasoactive drugs were less effective in septic compared to non-septic sheep. Most importantly, acute sepsis was characterized by a marked accumulation of fluid in an interstitial fluid space with slow turnover.
背景:晶体液体联合血管活性药物治疗急性脓毒症。我们采用动力学分析比较了血管活性药物对非脓毒症绵羊和脓毒症绵羊血液动力学和晶体液体积动力学的影响。特别关注药物和败血症对液体分布到“第三流体空间”的影响。方法:对49只绵羊进行实验研究,其中25只采用盲肠穿刺和脂多糖注射致脓毒症。1 h后滴注结晶液20- 25ml /kg,同时给予治疗剂量的苯肾上腺素、去甲肾上腺素、异丙肾上腺素、多巴胺或艾司洛尔。监测中心血流动力学,取血计算体积动力学。根据在180分钟内收集的1134次血红蛋白血浆稀释(每次实验23次)和193次尿量测量,使用混合模型动力学和广泛的协变量分析来计算输注体积的分布和消除。结果:脓毒症引起多动、低血压和血管舒张状态。脓毒症羊的平均心输出量为12.1 L/min,非脓毒症羊为7.6 L/min,平均动脉压分别为72和109 mmHg。非脓毒症和脓毒症绵羊的血流动力学变量差异均有统计学意义(pk10),脓毒症显著降低,β1-肾上腺素能刺激轻度降低,α1-肾上腺素能刺激升高。只有在败血症时,液体才能进入远端慢交换间质液空间(“第三液空间”)。理论上,α1-肾上腺素能刺激会减少该空间内的液体积聚,而β1-肾上腺素能刺激会增加该空间内的液体积聚,但由于肾上腺素能药物在脓毒症绵羊体内的整体作用较弱,因此差异较小。我们假设,从非败血症羊的尿流活跃到“第三液体空间”的明显积液的转变是由于炎症引起的间质基质的改变。结论:血管活性药物对脓毒症羊的治疗效果低于非脓毒症羊。最重要的是,急性脓毒症的特征是间质液空间中有明显的积液,且周转缓慢。
{"title":"Vasoactive drugs and the distribution of crystalloid fluid during acute sepsis","authors":"Robert G. Hahn ,&nbsp;Yuhong Li ,&nbsp;Randal O. Dull","doi":"10.1016/j.jointm.2025.08.008","DOIUrl":"10.1016/j.jointm.2025.08.008","url":null,"abstract":"<div><h3>Background</h3><div>Crystalloid fluid is combined with vasoactive drugs when treating acute sepsis. We used kinetic analysis to compare the effects of vasoactive drugs on the hemodynamics and the volume kinetics of crystalloid fluid in non-septic and septic sheep. Specific attention was given to the effects of drugs and sepsis on fluid distribution to the “third fluid space.”</div></div><div><h3>Methods</h3><div>Forty-nine sheep were studied, of which 25 were made septic by cecal puncture and administration of lipopolysaccharide. A bolus infusion of 20–25 mL/kg of crystalloid fluid was given 1 h later, together with therapeutic doses of phenylephrine, norepinephrine, isoprenaline, dopamine, or esmolol. Central hemodynamics were monitored, and blood samples for the calculation of volume kinetics were taken. The distribution and elimination of the infused volume were calculated using mixed-model kinetics with extensive covariate analyses based on 1134 measurements of the hemoglobin-derived plasma dilution (23 per experiment) and 193 measurements of urine output collected over 180 min.</div></div><div><h3>Results</h3><div>Sepsis induced a hyperkinetic, hypotensive, and vasodilatory state. Cardiac output averaged 12.1 L/min in septic sheep <em>vs</em>. 7.6 L/min in non-septic sheep, and mean arterial pressure was 72 <em>vs</em>. 109 mmHg, respectively. Differences in hemodynamic variables between the non-septic and septic sheep were all statistically significant (<em>P</em> &lt;0.001). However, the modifying influences of vasopressors on hemodynamics and fluid distribution were weakened in the septic state. The rate constant for urine output (<em>k</em><sub>10</sub>) was strongly decreased by sepsis, modestly reduced by β<sub>1</sub>-adrenergic stimulation, and increased by α<sub>1</sub>-adrenergic stimulation. Fluid was able to access the remote slow-exchange interstitial fluid space (“third fluid space”) only during sepsis. In theory, fluid accumulation in this space would decrease by α<sub>1</sub>-adrenergic stimulation and increase by β<sub>1</sub>-adrenergic stimulation, but differences were small due to the overall weak effects of adrenergic drugs in the septic sheep. We hypothesize that the changeover from brisk urine flow in the non-septic sheep to marked accumulation of fluid in the “third fluid space” was due to inflammation-induced alterations in the interstitial matrix.</div></div><div><h3>Conclusion</h3><div>Vasoactive drugs were less effective in septic compared to non-septic sheep. Most importantly, acute sepsis was characterized by a marked accumulation of fluid in an interstitial fluid space with slow turnover.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 75-82"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological development of the remote ventilate view platform for real-time monitoring of patient-ventilator asynchrony and respiratory parameters in severe pneumonia patients 重型肺炎患者实时监测患者-呼吸机不同步及呼吸参数的远程通气视图平台方方学开发
Pub Date : 2025-10-01 Epub Date: 2025-09-23 DOI: 10.1016/j.jointm.2025.07.003
Xiangyu Chen , Siyi Yuan , Elias Baedorf Kassis , Song Zhang , Yi Chi , Shengjun Liu , Fuhong Cai , Yue Ma , Yan Li , Longxiang Su , Yun Long

Background

Patient-ventilator asynchrony (PVA) is common in critically ill patients undergoing mechanical ventilation and may adversely affect clinical outcomes. Traditional bedside assessment methods are subjective and intermittent. We developed a real-time digital platform to continuously monitor ventilator waveforms and quantify overall asynchrony burden of severe pneumonia patients.

Methods

The study retrospectively analyzed mechanically ventilated coronavirus disease 2019 (COVID-19 patients admitted to the Department of Critical Care Medicine of Peking Union Medical College Hospital (PUMCH) from December 2022 to August 2023. Ventilator waveforms were continuously collected and processed using the remote ventilate view platform, which automatically identified eight PVA subtypes and calculated the Overall Asynchrony Index (OAI) across the full ventilation course. Respiratory mechanics were also extracted. Primary outcomes included intensive care unit (ICU) mortality and 28-day ventilator-free days (VFDs), while secondary outcomes included the length of ICU stay and duration of mechanical ventilation. The study used R, Jamovi, and Python for statistical analysis.

Results

Twenty-three mechanically ventilated COVID-19 patients admitted to the ICU at Peking Union Medical College Hospital were included in this study. No correlation was found between the index and ventilatory parameters, compliance, and disease severity. Patients with an OAI ≥10 % were more likely to have fewer 28-day VFDs (1.3 days vs. 11.4 days, P = 0.027) and were demonstrated to have a higher ICU mortality (66.7 % vs. 18.2 %, P = 0.036). Among eight types of PVA, flow insufficiency was found to be associated with prognosis (P = 0.012). OAI correlated with the prognosis of COVID-19 patients. Patients with an OAI ≥10 % were more likely to have fewer 28-day VFDs and higher ICU mortality.

Conclusions

A higher OAI and increased flow insufficiency were associated with worse outcomes in COVID-19 patients receiving mechanical ventilation. This study demonstrates the feasibility and clinical potential of a real-time, platform-based approach for automated detection and longitudinal monitoring of PVA.
患者-呼吸机不同步(PVA)在接受机械通气的危重患者中很常见,并可能对临床结果产生不利影响。传统的床边评估方法是主观的和间歇性的。我们开发了一个实时数字平台来连续监测呼吸机波形并量化重症肺炎患者的总体非同步负担。方法回顾性分析2022年12月至2023年8月北京协和医院重症医学科收治的2019冠状病毒病(COVID-19)患者。使用远程通气视图平台连续收集和处理呼吸机波形,自动识别8种PVA亚型并计算整个通气过程中的总体异步指数(OAI)。同时提取呼吸力学。主要结局包括重症监护病房(ICU)死亡率和28天无呼吸机天数(vfd),次要结局包括ICU住院时间和机械通气持续时间。本研究使用R、Jamovi和Python进行统计分析。结果入选北京协和医院重症监护病房机械通气的新冠肺炎患者23例。该指数与通气参数、依从性和疾病严重程度之间没有相关性。OAI≥10%的患者28天vfd更少(1.3天vs. 11.4天,P = 0.027), ICU死亡率更高(66.7% vs. 18.2%, P = 0.036)。在8种PVA类型中,血流不足与预后相关(P = 0.012)。OAI与COVID-19患者预后相关。OAI≥10%的患者更有可能出现较少的28天vfd和较高的ICU死亡率。结论采用机械通气的COVID-19患者OAI升高和血流不全加重与预后较差相关。本研究证明了实时、基于平台的PVA自动检测和纵向监测方法的可行性和临床潜力。
{"title":"Methodological development of the remote ventilate view platform for real-time monitoring of patient-ventilator asynchrony and respiratory parameters in severe pneumonia patients","authors":"Xiangyu Chen ,&nbsp;Siyi Yuan ,&nbsp;Elias Baedorf Kassis ,&nbsp;Song Zhang ,&nbsp;Yi Chi ,&nbsp;Shengjun Liu ,&nbsp;Fuhong Cai ,&nbsp;Yue Ma ,&nbsp;Yan Li ,&nbsp;Longxiang Su ,&nbsp;Yun Long","doi":"10.1016/j.jointm.2025.07.003","DOIUrl":"10.1016/j.jointm.2025.07.003","url":null,"abstract":"<div><h3>Background</h3><div>Patient-ventilator asynchrony (PVA) is common in critically ill patients undergoing mechanical ventilation and may adversely affect clinical outcomes. Traditional bedside assessment methods are subjective and intermittent. We developed a real-time digital platform to continuously monitor ventilator waveforms and quantify overall asynchrony burden of severe pneumonia patients.</div></div><div><h3>Methods</h3><div>The study retrospectively analyzed mechanically ventilated coronavirus disease 2019 (COVID-19 patients admitted to the Department of Critical Care Medicine of Peking Union Medical College Hospital (PUMCH) from December 2022 to August 2023. Ventilator waveforms were continuously collected and processed using the remote ventilate view platform, which automatically identified eight PVA subtypes and calculated the Overall Asynchrony Index (OAI) across the full ventilation course. Respiratory mechanics were also extracted. Primary outcomes included intensive care unit (ICU) mortality and 28-day ventilator-free days (VFDs), while secondary outcomes included the length of ICU stay and duration of mechanical ventilation. The study used R, Jamovi, and Python for statistical analysis.</div></div><div><h3>Results</h3><div>Twenty-three mechanically ventilated COVID-19 patients admitted to the ICU at Peking Union Medical College Hospital were included in this study. No correlation was found between the index and ventilatory parameters, compliance, and disease severity. Patients with an OAI ≥10 % were more likely to have fewer 28-day VFDs (1.3 days <em>vs</em>. 11.4 days, <em>P</em> = 0.027) and were demonstrated to have a higher ICU mortality (66.7 % <em>vs</em>. 18.2 %, <em>P</em> = 0.036). Among eight types of PVA, flow insufficiency was found to be associated with prognosis (<em>P</em> = 0.012). OAI correlated with the prognosis of COVID-19 patients. Patients with an OAI ≥10 % were more likely to have fewer 28-day VFDs and higher ICU mortality.</div></div><div><h3>Conclusions</h3><div>A higher OAI and increased flow insufficiency were associated with worse outcomes in COVID-19 patients receiving mechanical ventilation. This study demonstrates the feasibility and clinical potential of a real-time, platform-based approach for automated detection and longitudinal monitoring of PVA.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 4","pages":"Pages 367-376"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145335065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seeing Artery and VEin Simultaneously in the long axis (SAVES) for ultrasound-guided infraclavicular axillary/subclavian vein cannulation: A retrospective analysis 超声引导下锁骨下腋窝/锁骨下静脉插管长轴同时观察动、静脉的回顾性分析
Pub Date : 2025-10-01 Epub Date: 2025-07-03 DOI: 10.1016/j.jointm.2025.05.002
Ruyuan Zhang, Lei Li, Yaoqing Tang, Dechang Chen

Background

The anatomical configuration of the anterior scalene muscle, inserting between the subclavian vein and artery, creates a space between them. By placing an ultrasound probe in the infraclavicular area, an optimal longitudinal view of both the proximal part of the axillary and the distal part of the subclavian vein and artery can be obtained, while the pleura is out of view. This Seeing Artery and VEin Simultaneously in the long axis (SAVES) method for ultrasound-guided infraclavicular axillary/subclavian vein cannulation offers theoretical advantages because it may avoid iatrogenic pneumothorax and reduce the risk of arterial damage. The objective of the present study was, to our knowledge, for the first time, to determine the safety and efficacy of the SAVES method for ultrasound-guided infraclavicular axillary/subclavian vein cannulation in adult critically ill patients.

Methods

A retrospective study was performed on consecutive adult critically ill patients who underwent ultrasound-guided infraclavicular axillary/subclavian vein cannulation performed by the same physician in a medical/surgical intensive care unit (12 beds) between 20 August 2021 and 20 December 2024. The overall success rate, the first-pass success rate, the access time and number of attempts, the incidence of difficulty with insertion of the guidewire/dilator/catheter, and the mechanical complication rate were analyzed.

Results

A total of 111 adult critically ill patients required 142 ultrasound-guided infraclavicular axillary/subclavian vein punctures using the SAVES method. The overall success rate was 100%, and the first-pass success rate was 75.4%. The access time was 38.5 (interquartile range: 21.5–80.0) s. The proportions of different numbers (1, 2, and 3) of attempted catheterizations were 88.7%, 9.2%, and 2.1%, respectively. The incidence of difficulty with guidewire insertion was 15.5%, while no difficulty with insertion of the dilator or catheter was experienced. No instance of pneumothorax, hemothorax, arterial puncture, brachial plexus injury, or cardiac tamponade was recorded. The incidence of hematoma formation was 2.1%. The occurrence rate of posterior venous wall penetration was 3.5%. The catheter malposition rate was 5.6%.

Conclusions

The SAVES technique may be a safe and effective approach for ultrasound-guided infraclavicular axillary/subclavian vein cannulation. A larger controlled prospective study is warranted to confirm these findings.
前斜角肌的解剖结构插入锁骨下静脉和动脉之间,在它们之间创造了一个空间。通过在锁骨下区域放置超声探头,可以获得腋窝近端和锁骨下静脉和动脉远端最佳的纵向视图,而胸膜则不在视线范围内。超声引导下锁骨下腋窝/锁骨下静脉插管的长轴同时观察动脉和静脉(saved)方法具有理论上的优势,因为它可以避免医源性气胸并降低动脉损伤的风险。据我们所知,本研究的目的是首次确定超声引导下成人重症患者锁骨下腋窝/锁骨下静脉插管的安全性和有效性。方法回顾性研究2021年8月20日至2024年12月20日在某内科/外科重症监护病房(12张床位)由同一医师连续行超声引导下锁骨下腋窝/锁骨下静脉插管的成年危重患者。分析总成功率、一次通过率、入路时间及次数、导丝/扩张器/导管插入困难发生率及机械并发症发生率。结果111例成人危重患者采用超声引导下锁骨下腋窝/锁骨下静脉穿刺142次。整体成功率100%,一次通过成功率75.4%。获取时间为38.5秒(四分位间距为21.5 ~ 80.0秒),不同次数(1、2、3次)尝试置管的比例分别为88.7%、9.2%、2.1%。导丝插入困难的发生率为15.5%,而扩张器或导管的插入没有困难。无气胸、血胸、动脉穿刺、臂丛损伤或心包填塞病例记录。血肿发生率为2.1%。后静脉壁穿透率为3.5%。导管错位率为5.6%。结论超声引导下锁骨下腋窝/锁骨下静脉置管是一种安全有效的方法。有必要进行更大规模的对照前瞻性研究来证实这些发现。
{"title":"Seeing Artery and VEin Simultaneously in the long axis (SAVES) for ultrasound-guided infraclavicular axillary/subclavian vein cannulation: A retrospective analysis","authors":"Ruyuan Zhang,&nbsp;Lei Li,&nbsp;Yaoqing Tang,&nbsp;Dechang Chen","doi":"10.1016/j.jointm.2025.05.002","DOIUrl":"10.1016/j.jointm.2025.05.002","url":null,"abstract":"<div><h3>Background</h3><div>The anatomical configuration of the anterior scalene muscle, inserting between the subclavian vein and artery, creates a space between them. By placing an ultrasound probe in the infraclavicular area, an optimal longitudinal view of both the proximal part of the axillary and the distal part of the subclavian vein and artery can be obtained, while the pleura is out of view. This Seeing Artery and VEin Simultaneously in the long axis (SAVES) method for ultrasound-guided infraclavicular axillary/subclavian vein cannulation offers theoretical advantages because it may avoid iatrogenic pneumothorax and reduce the risk of arterial damage. The objective of the present study was, to our knowledge, for the first time, to determine the safety and efficacy of the SAVES method for ultrasound-guided infraclavicular axillary/subclavian vein cannulation in adult critically ill patients.</div></div><div><h3>Methods</h3><div>A retrospective study was performed on consecutive adult critically ill patients who underwent ultrasound-guided infraclavicular axillary/subclavian vein cannulation performed by the same physician in a medical/surgical intensive care unit (12 beds) between 20 August 2021 and 20 December 2024. The overall success rate, the first-pass success rate, the access time and number of attempts, the incidence of difficulty with insertion of the guidewire/dilator/catheter, and the mechanical complication rate were analyzed.</div></div><div><h3>Results</h3><div>A total of 111 adult critically ill patients required 142 ultrasound-guided infraclavicular axillary/subclavian vein punctures using the SAVES method. The overall success rate was 100%, and the first-pass success rate was 75.4%. The access time was 38.5 (interquartile range: 21.5–80.0) s. The proportions of different numbers (1, 2, and 3) of attempted catheterizations were 88.7%, 9.2%, and 2.1%, respectively. The incidence of difficulty with guidewire insertion was 15.5%, while no difficulty with insertion of the dilator or catheter was experienced. No instance of pneumothorax, hemothorax, arterial puncture, brachial plexus injury, or cardiac tamponade was recorded. The incidence of hematoma formation was 2.1%. The occurrence rate of posterior venous wall penetration was 3.5%. The catheter malposition rate was 5.6%.</div></div><div><h3>Conclusions</h3><div>The SAVES technique may be a safe and effective approach for ultrasound-guided infraclavicular axillary/subclavian vein cannulation. A larger controlled prospective study is warranted to confirm these findings.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 4","pages":"Pages 350-358"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145335105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
History of the Chinese medical association-Chinese society of critical care medicine 中华医学会史-中国危重医学学会
Pub Date : 2025-10-01 Epub Date: 2025-09-19 DOI: 10.1016/j.jointm.2025.08.005
Dechang Chen
{"title":"History of the Chinese medical association-Chinese society of critical care medicine","authors":"Dechang Chen","doi":"10.1016/j.jointm.2025.08.005","DOIUrl":"10.1016/j.jointm.2025.08.005","url":null,"abstract":"","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 4","pages":"Pages 295-297"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145332369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Videoart in the intensive care unit: A prospective observational study 录像艺术在重症监护病房:一项前瞻性观察研究
Pub Date : 2025-10-01 Epub Date: 2025-04-10 DOI: 10.1016/j.jointm.2025.02.001
Tomer Arad , Sabina Kalinchuk , Dina Grinas , Moran Hellerman-Itzhaki , Guy Fishman , Itai Bendavid , Liran Statlender , Ilya Kagan , Pierre Singer

Background

This study sought to evaluate the role of videoart in decreasing the risk of stress symptoms in patients hospitalized in the intensive care unit (ICU).

Methods

This is a prospective observational cohort study conducted in a general ICU in which 8 of 18 rooms are equipped with a videoart system. Competent patients who spent at least 48 h in the ICU were asked to complete an Impact of Events Scale (IES) questionnaire during hospitalization and at least 1 year after discharge. Patients were recruited from April 2017 until June 2020, and follow-up phone calls were made from June to August 2021. The primary outcome was an IES score indicative of significant stress symptoms during hospitalization. Secondary outcomes were IES scores indicative of significant stress symptoms after discharge and clinical parameters during hospital stay. The cut-off value for high-risk stress symptoms was 26. However, because there is uncertainty in the literature regarding the desired cut-off value, two other values were also analyzed. Outcomes that were found statistically significant were further examined using a logistic regression model for the control of confounders.

Results

Eighty-one patients completed the questionnaire during hospital stay and 24 patients after discharge. At home, patients who were exposed to videoart had a marginally lower mean IES score (median=6 [interquartile range: 0–18] vs. median=32 [interquartile range:10–45], P = 0.054) and a significantly lower rate of high-risk stress symptoms using the primary cut-off value (11.8 % vs. 57.1 %, P=0.038; odds ratio=10.00 95 % CI: 1.22 to 81.80, P=0.03). However, statistical significance was lost after adjustment for confounders (odds ratio=12.00, 95 % CI: 0.67 to 222.00, P=0.09) . There was no difference in the mean IES score, significant stress symptoms rate, or in any of the other endpoints examined during the hospital stay.

Conclusions

There is a trend toward the beneficial effect of videoart for the alleviation of stress symptoms among ICU patients. However, further study is needed to examine the role of this technology.
背景:本研究旨在评估视频治疗在降低重症监护病房(ICU)住院患者压力症状风险中的作用。方法:这是一项在普通ICU进行的前瞻性观察队列研究,其中18个房间中有8个配备了视频艺术系统。在ICU住院至少48小时的合格患者被要求在住院期间和出院后至少1年完成事件影响量表(IES)问卷调查。2017年4月至2020年6月招募患者,2021年6月至8月进行随访电话随访。主要结局是住院期间显著应激症状的IES评分。次要结局是显示出院后显著应激症状的IES评分和住院期间的临床参数。高危应激症状的临界值为26。然而,由于文献中关于期望的截止值存在不确定性,因此还分析了另外两个值。发现有统计学意义的结果进一步使用控制混杂因素的逻辑回归模型进行检查。结果81例患者住院期间完成问卷调查,24例出院后完成问卷调查。在家中,接触视频艺术的患者平均IES评分略低(中位数=6[四分位数范围:0-18]对中位数=32[四分位数范围:10-45],P= 0.054),使用主要临界值,高危应激症状发生率显著降低(11.8 %对57.1 %,P=0.038;比值比=10.00 95 % CI: 1.22至81.80,P=0.03)。然而,校正混杂因素后,没有统计学意义(优势比=12.00,95 % CI: 0.67 ~ 222.00, P=0.09)。在平均IES评分、显著的应激症状率或住院期间检查的任何其他终点方面没有差异。结论视频辅助治疗对缓解ICU患者的应激症状有良好的效果。然而,还需要进一步的研究来检验这项技术的作用。
{"title":"Videoart in the intensive care unit: A prospective observational study","authors":"Tomer Arad ,&nbsp;Sabina Kalinchuk ,&nbsp;Dina Grinas ,&nbsp;Moran Hellerman-Itzhaki ,&nbsp;Guy Fishman ,&nbsp;Itai Bendavid ,&nbsp;Liran Statlender ,&nbsp;Ilya Kagan ,&nbsp;Pierre Singer","doi":"10.1016/j.jointm.2025.02.001","DOIUrl":"10.1016/j.jointm.2025.02.001","url":null,"abstract":"<div><h3>Background</h3><div>This study sought to evaluate the role of videoart in decreasing the risk of stress symptoms in patients hospitalized in the intensive care unit (ICU).</div></div><div><h3>Methods</h3><div>This is a prospective observational cohort study conducted in a general ICU in which 8 of 18 rooms are equipped with a videoart system. Competent patients who spent at least 48 h in the ICU were asked to complete an Impact of Events Scale (IES) questionnaire during hospitalization and at least 1 year after discharge. Patients were recruited from April 2017 until June 2020, and follow-up phone calls were made from June to August 2021. The primary outcome was an IES score indicative of significant stress symptoms during hospitalization. Secondary outcomes were IES scores indicative of significant stress symptoms after discharge and clinical parameters during hospital stay. The cut-off value for high-risk stress symptoms was 26. However, because there is uncertainty in the literature regarding the desired cut-off value, two other values were also analyzed. Outcomes that were found statistically significant were further examined using a logistic regression model for the control of confounders.</div></div><div><h3>Results</h3><div>Eighty-one patients completed the questionnaire during hospital stay and 24 patients after discharge. At home, patients who were exposed to videoart had a marginally lower mean IES score (median=6 [interquartile range: 0–18] <em>vs.</em> median=32 [interquartile range:10–45], <em>P</em> = 0.054) and a significantly lower rate of high-risk stress symptoms using the primary cut-off value (11.8 % <em>vs.</em> 57.1 %, <em>P</em>=0.038; odds ratio=10.00 95 % CI: 1.22 to 81.80, <em>P</em>=0.03). However, statistical significance was lost after adjustment for confounders (odds ratio=12.00, 95 % CI: 0.67 to 222.00, <em>P</em>=0.09) . There was no difference in the mean IES score, significant stress symptoms rate, or in any of the other endpoints examined during the hospital stay.</div></div><div><h3>Conclusions</h3><div>There is a trend toward the beneficial effect of videoart for the alleviation of stress symptoms among ICU patients. However, further study is needed to examine the role of this technology.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 4","pages":"Pages 400-406"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145335104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practice pattern of aerosol drug therapy in ARDS patients: A secondary analysis of the Aero-in-ICU study 急性呼吸窘迫综合征(ARDS)患者气雾剂药物治疗的实践模式:icu气雾剂研究的二次分析
Pub Date : 2025-10-01 Epub Date: 2025-07-05 DOI: 10.1016/j.jointm.2025.05.003
Sanjay Singhal , Sai Saran , Krupal Joshi , Mohan Gurjar , Parnandi Bhaskar Rao , Jyoti Narayan Sahoo , Ruchi Dua , Alok Kumar Sahoo , Ankur Sharma , Sonika Agarwal , Arun Sharma , Pralay Shankar Ghosh , Nikhil Kothari , Kunal Deokar , Sudipta Mukherjee , Prakhar Sharma , BPS Sreedevi , Prakash Sivaramakrishnan , Umadri Singh , Dhivya Sundaram , Avinash Agrawal

Background

The potential role of aerosol drug therapy (ADT) in patients with acute respiratory distress syndrome (ARDS) remains uncertain. The objective of this study is to determine the prevalence and practice patterns of ADT in patients with ARDS.

Methods

This secondary analysis of a prospective observational multi-centric cohort study done in critically ill patients to know the ADT practice pattern was conducted in nine participating intensive care units (ICUs) across India between November 2022 and March 2023. The study recruited newly admitted adult patients (age >18 years) who had an artificial airway and required mechanical ventilation (invasive or non‑invasive). These patients were followed up for the next 14 days or until ICU discharge or death. This secondary analysis collected data about screened patients with ARDS, related to each aerosol therapy including ongoing respiratory support, type of drug, and aerosol‑generating device, including ongoing respiratory support, type of drug, and aerosol‑generating device.

Results

Fifty-three (24.3%) of the 218 patients had ARDS, with a mean age of (60.2±14.8) years. At admission, the acute physiology and chronic health evaluation (APACHE II) and sequential organ failure assessment (SOFA) score of the recruited patients were 17.4±7.1 and 7.7±4.0, respectively. Respiratory support was provided with invasive mechanical ventilation (IMV) alone, non-invasive ventilation (NIV) alone, or both in 45.3%, 24.5%, and 30.2% of patients, respectively. The mean duration of the ICU stay was (6.4 ± 4.0) days. Of the 53 patients with ARDS, 51 (96.2%) received 1285 aerosol sessions during follow-up for 330 patient days. Of all patients with ARDS who received aerosol therapy, 71.4% were prescribed while on IMV and 25.7% on NIV. A single drug was used in 60.7% of the aerosol sessions used a single drug, and 39.3% were prescribed combination drugs. Shorter-acting bronchodilators were the predominant drugs, with jet nebulizers (55.4%) being the most commonly used aerosol generators. These were followed by ultrasonic (23.1%) and vibrating-mesh nebulizers (21.5 %). During IMV, only in 50.1% of aerosol sessions (460 out of 918) was an aerosol generator placed at the optimum position (15–30 cm away from the Y-junction).

Conclusions

Aerosol therapy is frequently used in ARDS, with bronchodilators being the most common drug. The jet nebulizer is the most familiar aerosol-generating device, but only half of the aerosol sessions are at the optimum position during invasive mechanical ventilation.
背景:气溶胶药物治疗(ADT)在急性呼吸窘迫综合征(ARDS)患者中的潜在作用尚不确定。本研究的目的是确定急性呼吸窘迫综合征患者ADT的患病率和实践模式。方法对2022年11月至2023年3月期间在印度9个重症监护病房(icu)对危重患者进行的前瞻性观察性多中心队列研究进行二次分析,以了解ADT实践模式。该研究招募了新入院的成年患者(年龄18岁),他们使用人工气道并需要机械通气(有创或无创)。随访14天或至ICU出院或死亡。该二次分析收集了筛选的ARDS患者的数据,这些数据与每种气溶胶治疗相关,包括持续的呼吸支持、药物类型和气溶胶产生装置,包括持续的呼吸支持、药物类型和气溶胶产生装置。结果218例ARDS患者中53例(24.3%)发生ARDS,平均年龄(60.2±14.8)岁。入院时,患者的急性生理和慢性健康评估(APACHE II)评分为17.4±7.1分,序事性器官衰竭评估(SOFA)评分为7.7±4.0分。分别有45.3%、24.5%和30.2%的患者采用有创机械通气(IMV)、无创通气(NIV)或两者同时提供呼吸支持。ICU平均住院时间为(6.4±4.0)d。在53例ARDS患者中,51例(96.2%)在随访期间接受了1285次气溶胶治疗,随访时间为330个患者日。在所有接受气雾剂治疗的急性呼吸窘迫综合征患者中,71.4%的患者同时服用IMV, 25.7%的患者同时服用NIV。在使用单一药物的气雾剂疗程中,使用单一药物的占60.7%,使用联合药物的占39.3%。短效支气管扩张剂是主要药物,喷射雾化器是最常用的气溶胶发生器(55.4%)。其次是超声波雾化器(23.1%)和振动网雾化器(21.5%)。在IMV过程中,只有50.1%的气溶胶试验(918次试验中的460次)将气溶胶发生器放置在最佳位置(距离y型交界处15-30厘米)。结论雾化治疗是ARDS常用的治疗方法,支气管扩张剂是最常用的药物。喷射喷雾器是最常见的气溶胶产生装置,但在有创机械通气过程中,只有一半的气溶胶处于最佳位置。
{"title":"Practice pattern of aerosol drug therapy in ARDS patients: A secondary analysis of the Aero-in-ICU study","authors":"Sanjay Singhal ,&nbsp;Sai Saran ,&nbsp;Krupal Joshi ,&nbsp;Mohan Gurjar ,&nbsp;Parnandi Bhaskar Rao ,&nbsp;Jyoti Narayan Sahoo ,&nbsp;Ruchi Dua ,&nbsp;Alok Kumar Sahoo ,&nbsp;Ankur Sharma ,&nbsp;Sonika Agarwal ,&nbsp;Arun Sharma ,&nbsp;Pralay Shankar Ghosh ,&nbsp;Nikhil Kothari ,&nbsp;Kunal Deokar ,&nbsp;Sudipta Mukherjee ,&nbsp;Prakhar Sharma ,&nbsp;BPS Sreedevi ,&nbsp;Prakash Sivaramakrishnan ,&nbsp;Umadri Singh ,&nbsp;Dhivya Sundaram ,&nbsp;Avinash Agrawal","doi":"10.1016/j.jointm.2025.05.003","DOIUrl":"10.1016/j.jointm.2025.05.003","url":null,"abstract":"<div><h3>Background</h3><div>The potential role of aerosol drug therapy (ADT) in patients with acute respiratory distress syndrome (ARDS) remains uncertain. The objective of this study is to determine the prevalence and practice patterns of ADT in patients with ARDS.</div></div><div><h3>Methods</h3><div>This secondary analysis of a prospective observational multi-centric cohort study done in critically ill patients to know the ADT practice pattern was conducted in nine participating intensive care units (ICUs) across India between November 2022 and March 2023. The study recruited newly admitted adult patients (age &gt;18 years) who had an artificial airway and required mechanical ventilation (invasive or non‑invasive). These patients were followed up for the next 14 days or until ICU discharge or death. This secondary analysis collected data about screened patients with ARDS, related to each aerosol therapy including ongoing respiratory support, type of drug, and aerosol‑generating device, including ongoing respiratory support, type of drug, and aerosol‑generating device.</div></div><div><h3>Results</h3><div>Fifty-three (24.3%) of the 218 patients had ARDS, with a mean age of (60.2±14.8) years. At admission, the acute physiology and chronic health evaluation (APACHE II) and sequential organ failure assessment (SOFA) score of the recruited patients were 17.4±7.1 and 7.7±4.0, respectively. Respiratory support was provided with invasive mechanical ventilation (IMV) alone, non-invasive ventilation (NIV) alone, or both in 45.3%, 24.5%, and 30.2% of patients, respectively. The mean duration of the ICU stay was (6.4 ± 4.0) days. Of the 53 patients with ARDS, 51 (96.2%) received 1285 aerosol sessions during follow-up for 330 patient days. Of all patients with ARDS who received aerosol therapy, 71.4% were prescribed while on IMV and 25.7% on NIV. A single drug was used in 60.7% of the aerosol sessions used a single drug, and 39.3% were prescribed combination drugs. Shorter-acting bronchodilators were the predominant drugs, with jet nebulizers (55.4%) being the most commonly used aerosol generators. These were followed by ultrasonic (23.1%) and vibrating-mesh nebulizers (21.5 %). During IMV, only in 50.1% of aerosol sessions (460 out of 918) was an aerosol generator placed at the optimum position (15–30 cm away from the Y-junction).</div></div><div><h3>Conclusions</h3><div>Aerosol therapy is frequently used in ARDS, with bronchodilators being the most common drug. The jet nebulizer is the most familiar aerosol-generating device, but only half of the aerosol sessions are at the optimum position during invasive mechanical ventilation.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 4","pages":"Pages 385-391"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145335067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ICU readmission and mortality risk prediction: Generalizability of a multi-hospital model ICU再入院和死亡风险预测:多医院模型的通用性
Pub Date : 2025-10-01 Epub Date: 2025-06-14 DOI: 10.1016/j.jointm.2025.03.007
Tariq A. Dam , Daan de Bruin , Giovanni Cinà , Patrick J. Thoral , Paul W.G. Elbers , Corstiaan A. den Uil , Reinier F. Crane

Background

Inadvertent intensive care unit (ICU) readmission is associated with longer length of stay and increased mortality. Conversely, delayed ICU discharge may represent inefficient use of resources. To better inform discharge timing, several hospitals have implemented machine learning models to predict readmission risk following discharge. However, these models are typically created locally and may not generalize well to other hospitals or patient populations. A single multi-hospital-based model might provide more accurate predictions and insight into features that are applicable across diverse clinical settings.

Methods

This study involved a retrospective multi-center cohort from one academic hospital (Amsterdam University Medical Center [AUMC]) and two large teaching hospitals (Maasstad Ziekenhuis [MSZ] and OLVG). Data from the latter two hospitals were combined to create a pooled model, which was tested on the academic hospital dataset. Data relating to all adult ICU patients were included, starting from the implementation of the electronic health record system until the commencement of model development for each hospital. An XGBoost model was trained to predict a composite outcome of readmission or mortality within 7 days and an autoencoder was used as an out-of-distribution (OOD) detector to capture dataset heterogeneity.

Results

In total, 44,837 patients were available for analysis across the three hospitals. The average readmission rates were 7.1 %, 6.9 %, and 5.9 % for MSZ, OLVG, and AUMC, respectively. Performance evaluation of the local models on AUMC data demonstrated weighted area under the receiver operating characteristic curves of 69.7 %±0.8 %, 70.5 %±0.5 %, and 76.5 %±1.9 %, respectively, whereas the pooled model achieved a weighted area under the receiver operating characteristic curves of 71.1 %±0.7 %. The difference between internal and external performance was reduced when cardiac surgery patients were excluded. The key features across models were albumin levels and the use of oxygen therapy.

Discussion

A single, multi-hospital-based model performed comparably on external datasets, especially when cardiac surgery patients were excluded. However, when applied externally, model predictions risk being uncalibrated for specific patient subgroups and require careful calibration before implementation. While external models were more stable than local ones over OOD scores, their performance was comparable after excluding cardiac surgery patients. Although pooling data marginally improved performance on external datasets, the incorporation of data from diverse hospitals is likely to provide greater benefits.
背景:重症监护病房(ICU)再入院与住院时间延长和死亡率增加有关。相反,延迟ICU出院可能代表资源利用效率低下。为了更好地了解出院时间,几家医院已经实施了机器学习模型来预测出院后的再入院风险。然而,这些模型通常是在当地创建的,可能无法很好地推广到其他医院或患者群体。单一的基于多医院的模型可能提供更准确的预测和对适用于不同临床环境的特征的洞察。方法采用一所学术医院(阿姆斯特丹大学医学中心[AUMC])和两所大型教学医院(Maasstad Ziekenhuis [MSZ]和OLVG)的回顾性多中心队列研究。后两家医院的数据被结合起来创建了一个汇总模型,并在学术医院数据集上进行了测试。从电子健康记录系统的实施开始,直到每家医院的模型开发开始,所有成人ICU患者的数据都被纳入其中。训练XGBoost模型来预测7天内再入院或死亡的综合结果,并使用自动编码器作为分布外(OOD)检测器来捕获数据集异质性。结果三所医院共收集患者44837例。MSZ、OLVG和AUMC的平均再入院率分别为7.1 %、6.9 %和5.9 %。局部模型在AUMC数据上的性能评价显示,受者工作特征曲线下的加权面积分别为69.7 %±0.8 %、70.5 %±0.5 %和76.5 %±1.9 %,而合并模型在受者工作特征曲线下的加权面积为71.1 %±0.7 %。当排除心脏手术患者时,内部和外部表现的差异减小。各模型的关键特征是白蛋白水平和氧治疗的使用。基于单一、多医院的模型在外部数据集上的表现相当,特别是在排除心脏手术患者的情况下。然而,在外部应用时,模型预测有可能无法针对特定患者亚组进行校准,并且在实施之前需要仔细校准。虽然外部模型在OOD评分上比局部模型更稳定,但在排除心脏手术患者后,它们的表现是相当的。虽然汇集数据略微提高了外部数据集的性能,但合并来自不同医院的数据可能会带来更大的好处。
{"title":"ICU readmission and mortality risk prediction: Generalizability of a multi-hospital model","authors":"Tariq A. Dam ,&nbsp;Daan de Bruin ,&nbsp;Giovanni Cinà ,&nbsp;Patrick J. Thoral ,&nbsp;Paul W.G. Elbers ,&nbsp;Corstiaan A. den Uil ,&nbsp;Reinier F. Crane","doi":"10.1016/j.jointm.2025.03.007","DOIUrl":"10.1016/j.jointm.2025.03.007","url":null,"abstract":"<div><h3>Background</h3><div>Inadvertent intensive care unit (ICU) readmission is associated with longer length of stay and increased mortality. Conversely, delayed ICU discharge may represent inefficient use of resources. To better inform discharge timing, several hospitals have implemented machine learning models to predict readmission risk following discharge. However, these models are typically created locally and may not generalize well to other hospitals or patient populations. A single multi-hospital-based model might provide more accurate predictions and insight into features that are applicable across diverse clinical settings.</div></div><div><h3>Methods</h3><div>This study involved a retrospective multi-center cohort from one academic hospital (Amsterdam University Medical Center [AUMC]) and two large teaching hospitals (Maasstad Ziekenhuis [MSZ] and OLVG). Data from the latter two hospitals were combined to create a pooled model, which was tested on the academic hospital dataset. Data relating to all adult ICU patients were included, starting from the implementation of the electronic health record system until the commencement of model development for each hospital. An XGBoost model was trained to predict a composite outcome of readmission or mortality within 7 days and an autoencoder was used as an out-of-distribution (OOD) detector to capture dataset heterogeneity.</div></div><div><h3>Results</h3><div>In total, 44,837 patients were available for analysis across the three hospitals. The average readmission rates were 7.1 %, 6.9 %, and 5.9 % for MSZ, OLVG, and AUMC, respectively. Performance evaluation of the local models on AUMC data demonstrated weighted area under the receiver operating characteristic curves of 69.7 %±0.8 %, 70.5 %±0.5 %, and 76.5 %±1.9 %, respectively, whereas the pooled model achieved a weighted area under the receiver operating characteristic curves of 71.1 %±0.7 %. The difference between internal and external performance was reduced when cardiac surgery patients were excluded. The key features across models were albumin levels and the use of oxygen therapy.</div></div><div><h3>Discussion</h3><div>A single, multi-hospital-based model performed comparably on external datasets, especially when cardiac surgery patients were excluded. However, when applied externally, model predictions risk being uncalibrated for specific patient subgroups and require careful calibration before implementation. While external models were more stable than local ones over OOD scores, their performance was comparable after excluding cardiac surgery patients. Although pooling data marginally improved performance on external datasets, the incorporation of data from diverse hospitals is likely to provide greater benefits.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 4","pages":"Pages 377-384"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145335068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Joint application of multiplex drop-off digital PCR, droplet digital PCR, and metagenomic next-generation sequencing for the diagnosis of suspected infectious diseases: A retrospective cohort study 多重滴入式数字PCR、微滴式数字PCR和新一代宏基因组测序在疑似传染病诊断中的联合应用:一项回顾性队列研究
Pub Date : 2025-10-01 Epub Date: 2025-05-14 DOI: 10.1016/j.jointm.2025.03.006
Shanshan Jin , Shiyu Meng , Qiuping Huang , Hui Xie , Jingjing Zheng , Ruilan Wang

Background

Critically ill patients in ICUs are highly vulnerable to infectious diseases. Early and accurate identification of pathogens is vital for initiating appropriate antimicrobial therapy. To evaluate the diagnostic effectiveness in patients with suspected infectious diseases; three different molecular technologies and conventional microbiological tests were used.

Methods

A total of 97 individuals suspected of having infectious diseases were retrospectively enrolled from July 2023 to January 2024 at Shanghai General Hospital. Samples were collected for metagenomic next-generation sequencing (mNGS), droplet digital polymerase chain reaction (ddPCR), multiplex drop-off digital polymerase chain reaction (MDO-dPCR), and conventional microbiological tests (CMTs) for suspected pathogen detection. The diagnostic efficacies of the three molecular technologies and CMTs were compared, and the effects of their joint application on clinical outcomes were evaluated. Intergroup comparisons were performed using the Kruskal–Wallis test, with a P-value <0.05 considered statistically significant.

Results

Joint detection exhibited a high negative predictive value. The sensitivity of MDO-dPCR, ddPCR, and mNGS was 52.6%, 48.5%, and 96.6%, respectively; and the corresponding specificity was 72.5%, 73.3%, and 50.0%. A positive correlation was observed between pathogen copies detected using MDO-dPCR and procalcitonin (Pearson’s ρ=0.21, P=0.039), acute physiology and chronic health evaluation II (Pearson’s ρ=0.24, P =0.018), and sequential organ failure assessment (Pearson’s ρ=0.25, P=0.012). Therapeutic regimens were adjusted in 51.5% of the patients (50/97) based on the results of the combination tests.

Conclusions

In the present study, we highlighted the significance of molecular technologies for the early diagnosis of patients with suspected infections. These technologies can serve as a complement to CMTs and should be implemented promptly to guide clinicians in providing timely and effective anti-infective treatments. Future studies should aim to confirm these findings in large-scale clinical trials to refine diagnostic protocols, while also incorporating cost-utility analyses.
重症监护病房危重患者极易感染传染病。早期和准确识别病原体对于开始适当的抗菌治疗至关重要。评价对疑似传染病患者的诊断效果;使用了三种不同的分子技术和常规微生物试验。方法回顾性分析上海总医院于2023年7月至2024年1月收治的97例疑似感染性疾病患者。收集样本进行新一代宏基因组测序(mNGS)、微滴数字聚合酶链反应(ddPCR)、多重滴入数字聚合酶链反应(mda - dpcr)和常规微生物检测(cmt),以检测疑似病原体。比较三种分子技术与cmt的诊断效果,并评价其联合应用对临床预后的影响。组间比较采用Kruskal-Wallis检验,p值<;0.05认为有统计学意义。结果联合检测具有较高的阴性预测值。MDO-dPCR、ddPCR和mNGS的敏感性分别为52.6%、48.5%和96.6%;特异性分别为72.5%、73.3%和50.0%。MDO-dPCR检测的病原体拷贝数与降钙素原(Pearson’s ρ=0.21, P=0.039)、急性生理和慢性健康评估II (Pearson’s ρ=0.24, P= 0.018)、序贯器官衰竭评估(Pearson’s ρ=0.25, P=0.012)呈正相关。51.5%的患者(50/97)根据联合试验的结果调整了治疗方案。结论在本研究中,我们强调了分子技术对疑似感染患者早期诊断的意义。这些技术可作为cmt的补充,应及时实施,以指导临床医生提供及时有效的抗感染治疗。未来的研究应该致力于在大规模临床试验中证实这些发现,以完善诊断方案,同时也纳入成本-效用分析。
{"title":"Joint application of multiplex drop-off digital PCR, droplet digital PCR, and metagenomic next-generation sequencing for the diagnosis of suspected infectious diseases: A retrospective cohort study","authors":"Shanshan Jin ,&nbsp;Shiyu Meng ,&nbsp;Qiuping Huang ,&nbsp;Hui Xie ,&nbsp;Jingjing Zheng ,&nbsp;Ruilan Wang","doi":"10.1016/j.jointm.2025.03.006","DOIUrl":"10.1016/j.jointm.2025.03.006","url":null,"abstract":"<div><h3>Background</h3><div>Critically ill patients in ICUs are highly vulnerable to infectious diseases. Early and accurate identification of pathogens is vital for initiating appropriate antimicrobial therapy. To evaluate the diagnostic effectiveness in patients with suspected infectious diseases; three different molecular technologies and conventional microbiological tests were used.</div></div><div><h3>Methods</h3><div>A total of 97 individuals suspected of having infectious diseases were retrospectively enrolled from July 2023 to January 2024 at Shanghai General Hospital. Samples were collected for metagenomic next-generation sequencing (mNGS), droplet digital polymerase chain reaction (ddPCR), multiplex drop-off digital polymerase chain reaction (MDO-dPCR), and conventional microbiological tests (CMTs) for suspected pathogen detection. The diagnostic efficacies of the three molecular technologies and CMTs were compared, and the effects of their joint application on clinical outcomes were evaluated. Intergroup comparisons were performed using the Kruskal–Wallis test, with a <em>P</em>-value &lt;0.05 considered statistically significant.</div></div><div><h3>Results</h3><div>Joint detection exhibited a high negative predictive value. The sensitivity of MDO-dPCR, ddPCR, and mNGS was 52.6%, 48.5%, and 96.6%, respectively; and the corresponding specificity was 72.5%, 73.3%, and 50.0%. A positive correlation was observed between pathogen copies detected using MDO-dPCR and procalcitonin (Pearson’s <em>ρ</em>=0.21, <em>P</em>=0.039), acute physiology and chronic health evaluation II (Pearson’s <em>ρ</em>=0.24, <em>P</em> =0.018), and sequential organ failure assessment (Pearson’s <em>ρ</em>=0.25, <em>P</em>=0.012). Therapeutic regimens were adjusted in 51.5% of the patients (50/97) based on the results of the combination tests.</div></div><div><h3>Conclusions</h3><div>In the present study, we highlighted the significance of molecular technologies for the early diagnosis of patients with suspected infections. These technologies can serve as a complement to CMTs and should be implemented promptly to guide clinicians in providing timely and effective anti-infective treatments. Future studies should aim to confirm these findings in large-scale clinical trials to refine diagnostic protocols, while also incorporating cost-utility analyses.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 4","pages":"Pages 407-418"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145335103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe invasive Streptococcus pyogenes infections: A 15-year observational study with molecular characterization of isolates among intensive care adults 严重侵袭性化脓性链球菌感染:重症监护成人分离株分子特征的15年观察性研究
Pub Date : 2025-10-01 Epub Date: 2025-09-04 DOI: 10.1016/j.jointm.2025.06.001
Loreto Vidaur , Izaskun Azkarate , Estibaliz Salas , Iñigo Ansa , Diego Vicente , Jordi Rello , Milagrosa Montes

Background

Improving outcomes among patients with invasive group A Streptococcus pyogenes (iGAS) infections is an unmet clinical need. The main objective of this study was to analyze epidemiological and outcome differences in adults admitted to the intensive care unit (ICU) with iGAS infection over a 15-year period and to evaluate the impact of M1uk isolates and clindamycin optimization on patient outcomes.

Methods

This was a single-center observational study conducted at the ICU of Donostia University Hospital, located in Donostia, Spain. The recruitment of all consecutive adult patients admitted to the ICU by iGAS was carried out from January 2010 to May 2024 and divided into three periods: pre-pandemic (January 2010–2019), pandemic (2020–2021), and post-pandemic (May 2022–2024). The main outcome variables were ICU length of stay, hospital length of stay, and ICU mortality. Data were analyzed using the Statistical Package for the Social Sciences (SPSS) software (version 25; SPSS Inc., Chicago, IL, USA). A significance level of P <0.05 was considered for all analyses.

Results

Sixty-eight adults were enrolled, with a crude mortality in pre- and post-pandemic periods being 25.5% and 10.0% (P=0.200), respectively. Twenty (29.4%) were respiratory and 29 (41.2%) were soft tissue infections. The incidence had valleys (<1/100,000) in 2020 and 2021 and peaks (>4/100,000 inhabitants) in 2014, 2019, and 2023. Pre-pandemic patients were significantly younger (median: 58.0 vs. 67.5 years, P <0.050), had lower Charlson scores (median: 0 vs. 2, P=0.009), and required more renal replacement therapy (48.9% vs. 15.0%, P=0.013). Emm1 type was the most frequent isolated strain, with the M1uk lineage being represented in 6 out of 7 Emm1 isolates in post-pandemic period. M1uk-infected patients were older (median: 67.0 vs. 50.0 years, P=0.073) but mortality was similar. Most patients (86.6%) received β-lactams plus clindamycin. Interestingly, time to clindamycin administration was earlier (median: 1 h vs. 24 h; P <0.050) in the post-pandemic period with a 5-fold increase in ICU mortality (5.6% to 26.5%, OR=6.14, 95% CI: 0.74 to 50.85; P=0.090) among those adults who did not receive clindamycin in the emergency department.

Conclusions

The incidence of iGAS infections requiring ICU admission showed no significant increase post-Coronavirus Disease-19 pandemic. The highly toxigenic M1uk strain became predominant, but it was not associated with worse mortality among adult ICU patients.
背景:改善侵袭性A组化脓性链球菌(iGAS)感染患者的预后是一个尚未满足的临床需求。本研究的主要目的是分析15年期间iGAS感染入住重症监护病房(ICU)的成人的流行病学和结局差异,并评估M1uk分离株和克林霉素优化对患者结局的影响。方法本研究是在西班牙多诺斯蒂亚大学医院ICU进行的单中心观察性研究。从2010年1月至2024年5月,通过iGAS连续招募所有ICU成年患者,并将其分为三个时期:大流行前(2010年1月- 2019年)、大流行前(2020年- 2021年)和大流行后(2022年5月- 2024年)。主要结局变量为ICU住院时间、住院时间和ICU死亡率。数据分析使用社会科学统计软件包(SPSS)软件(版本25;SPSS Inc.,芝加哥,伊利诺伊州,美国)。所有分析均考虑P <;0.05的显著性水平。结果纳入68名成人,大流行前和大流行后的粗死亡率分别为25.5%和10.0% (P=0.200)。呼吸道感染20例(29.4%),软组织感染29例(41.2%)。发病率在2020年和2021年出现低谷(1/10万人),在2014年、2019年和2023年出现高峰(4/10万人)。大流行前的患者明显更年轻(中位数:58.0比67.5岁,P <0.050), Charlson评分较低(中位数:0比2,P=0.009),并且需要更多的肾脏替代治疗(48.9%比15.0%,P=0.013)。Emm1型是最常见的分离株,在大流行后时期,7株Emm1分离株中有6株为M1uk谱系。m1uk感染的患者年龄较大(中位数:67.0 vs 50.0岁,P=0.073),但死亡率相似。大多数患者(86.6%)接受β-内酰胺类药物联合克林霉素治疗。有趣的是,大流行后给予克林霉素的时间更早(中位数:1小时对24小时;P <0.050),在急诊科未接受克林霉素治疗的成年人中,ICU死亡率增加了5倍(5.6%至26.5%,OR=6.14, 95% CI: 0.74至50.85;P=0.090)。结论2019冠状病毒病大流行后ICU住院iGAS感染发生率无明显增加。高毒力的M1uk菌株成为优势菌株,但它与ICU成人患者较差的死亡率无关。
{"title":"Severe invasive Streptococcus pyogenes infections: A 15-year observational study with molecular characterization of isolates among intensive care adults","authors":"Loreto Vidaur ,&nbsp;Izaskun Azkarate ,&nbsp;Estibaliz Salas ,&nbsp;Iñigo Ansa ,&nbsp;Diego Vicente ,&nbsp;Jordi Rello ,&nbsp;Milagrosa Montes","doi":"10.1016/j.jointm.2025.06.001","DOIUrl":"10.1016/j.jointm.2025.06.001","url":null,"abstract":"<div><h3>Background</h3><div>Improving outcomes among patients with invasive group A <em>Streptococcus pyogenes</em> (iGAS) infections is an unmet clinical need. The main objective of this study was to analyze epidemiological and outcome differences in adults admitted to the intensive care unit (ICU) with iGAS infection over a 15-year period and to evaluate the impact of M1uk isolates and clindamycin optimization on patient outcomes.</div></div><div><h3>Methods</h3><div>This was a single-center observational study conducted at the ICU of Donostia University Hospital, located in Donostia, Spain. The recruitment of all consecutive adult patients admitted to the ICU by iGAS was carried out from January 2010 to May 2024 and divided into three periods: pre-pandemic (January 2010–2019), pandemic (2020–2021), and post-pandemic (May 2022–2024). The main outcome variables were ICU length of stay, hospital length of stay, and ICU mortality. Data were analyzed using the Statistical Package for the Social Sciences (SPSS) software (version 25; SPSS Inc., Chicago, IL, USA). A significance level of <em>P</em> &lt;0.05 was considered for all analyses.</div></div><div><h3>Results</h3><div>Sixty-eight adults were enrolled, with a crude mortality in pre- and post-pandemic periods being 25.5% and 10.0% (<em>P</em>=0.200), respectively. Twenty (29.4%) were respiratory and 29 (41.2%) were soft tissue infections. The incidence had valleys (&lt;1/100,000) in 2020 and 2021 and peaks (&gt;4/100,000 inhabitants) in 2014, 2019, and 2023. Pre-pandemic patients were significantly younger (median: 58.0 <em>vs.</em> 67.5 years, <em>P</em> &lt;0.050), had lower Charlson scores (median: 0 <em>vs.</em> 2, <em>P</em>=0.009), and required more renal replacement therapy (48.9% <em>vs.</em> 15.0%, <em>P</em>=0.013). <em>Emm1</em> type was the most frequent isolated strain, with the M1uk lineage being represented in 6 out of 7 <em>Emm1</em> isolates in post-pandemic period. M1uk-infected patients were older (median: 67.0 <em>vs.</em> 50.0 years, <em>P</em>=0.073) but mortality was similar. Most patients (86.6%) received β-lactams plus clindamycin. Interestingly, time to clindamycin administration was earlier (median: 1 h <em>vs.</em> 24 h; <em>P</em> &lt;0.050) in the post-pandemic period with a 5-fold increase in ICU mortality (5.6% to 26.5%, OR=6.14, 95% CI: 0.74 to 50.85; <em>P</em>=0.090) among those adults who did not receive clindamycin in the emergency department.</div></div><div><h3>Conclusions</h3><div>The incidence of iGAS infections requiring ICU admission showed no significant increase post-Coronavirus Disease-19 pandemic. The highly toxigenic M1uk strain became predominant, but it was not associated with worse mortality among adult ICU patients.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 4","pages":"Pages 336-343"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145335149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of intensive medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1